Pharmaceutical Fraud

Skip to main content CASES Tipline 1-888-381-2889 Main navigation Cases Attorneys All Attorneys Steve W. Berman, Managing Partner Thomas M. Sobol, Executive Robert B. Carey, Executive France Team U.K. Team Newsroom Press Releases Blog Practices Anti-Terrorism Antitrust Litigation Automotive Litigation Child Sexual Abuse Civil & Human Rights Litigation Class Action Consumer Rights Data Breach, Privacy & Cybersecurity Emissions Litigation Employment Litigation Environmental Litigation First Responder Litigation Governmental Representation High Tech Litigation Intellectual Property Investor Fraud Personal Injury Litigation Pharmaceutical Fraud Pharmaceutical Fraud Practice Pharmaceutical Fraud Legal Team Sexual Abuse & Harassment Sports Litigation Veterans & Military Servicemember Litigation Whistleblower About About the Firm Firm Story In the Media Our Advantage Contingency Fee Working at Hagens Berman Cycling Teams Success Landmark Cases Victories & Settlements Awards & Recognition Testimonials Contact Contact Us Offices Media Inquiries Careers Pharmaceutical Fraud Main navigation Pharmaceutical Fraud Practice Pharmaceutical Fraud Legal Team Hagens Berman’s lawyers fight rising prescription drug and healthcare costs, taking on the world’s largest pharmaceutical manufacturers and others in the healthcare distribution chain. Our team is second to none in this field, using antitrust, RICO and state consumer-protection laws against Big Pharma. Hagens Berman’s attorneys exert extensive litigation and courtroom experience. We originate and focus on cutting-edge healthcare antitrust and fraud litigation, using antitrust, state consumer-protection laws and RICO to improve the quality and fairness of our healthcare and prescription drug system. We represent consumers and other purchasers, governmental entities, and the nation’s most forward-thinking public interest groups. Our cases combat pay-for-delay deals threatening to keep generics off the market, tackle misrepresentations about the safety and efficacy of prescription drugs, and hold opioid manufacturers and others accountable for the scourge affecting this country. Dogged in our efforts, our team has pursued these cases since the firm’s founding and have collectively hundreds of years of experience holding Big Pharma accountable. Through these complex litigation efforts Hagens Berman has recovered billions of dollars in recovery for drug purchasers. Some of the areas covered by our practice include: PAY-FOR-DELAY AND OTHER ANTITRUST LITIGATION Big Pharma employs no shortage of tricks to unlawfully extend monopolies on brand and biologic drugs, leaving consumers and other drug purchasers to pay more than they should for prescriptions, for longer than they should. Our legal team is skilled in targeting sham patent filings, phony infringement litigation filed by pharma companies, and pay-for-delay schemes used to corner the market at the expense of those who need medications to live a healthy, happy life. We have negotiated billions of dollars in settlements on behalf of clients and classes, including consumers and governments, who we alleged overpaid for drugs due to price-inflation schemes. No firm in the world matches our experience in this arena. Glumetza Antitrust Litigation Ranbaxy Generic Drug Application Antitrust Litigation Actos Antitrust Litigation Revlimid Antitrust Litigation Intuniv Antitrust Litigation Xyrem Antitrust Litigation MARKETING AND FRAUD CASES Hagens Berman’s lawyers have brought numerous cases alleging that pharmaceutical manufacturers misrepresented the safety and efficacy of their drugs or unlawfully marketed their drugs for uses for which they aren’t approved or efficacious, causing both personal and economic injury to consumers and other purchasers. We have also pursued Big Pharma and others in the healthcare distribution chain for intentionally inflating reported prices for prescription medications. Our efforts in this space have resulted in billions of dollars returned to consumers and other payors, and billions more in savings on prescription drugs. Avandia Marketing, Sales and Products Liability Litigation Neurontin Marketing and Sales Practices Litigation DRUG-PRICING MANIPULATION Hagens Berman has been at the forefront of challenging the pharmaceutical industry’s anticompetitive pricing practices, including fighting against industry-wide inflation of drug-pricing benchmarks and manipulation of the spread between what pharmaceutical benefit managers pay and the price consumers pay for insulin. Insulin Pricing Litigation Average Wholesale Prices (AWP) Litigation First Databank PERSONAL INJURY LAWSUITS When pharmaceutical or compounding companies negligently market or distribute dangerous drugs or medical devices to the public, we take legal action, pursuing justice for patients. New England